# A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT

> **NCT05171894** · PHASE2 · RECRUITING · sponsor: **Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.** · enrollment: 84 (estimated)

## Conditions studied

- Port-wine Birthmarks
- Port-Wine Stain
- Nevus Flammeus

## Interventions

- **DRUG:** Hemopfin+Green Light
- **DEVICE:** Vehicle+Green Light

## Key facts

- **NCT ID:** NCT05171894
- **Lead sponsor:** Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-21
- **Primary completion:** 2027-01
- **Final completion:** 2027-04
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05171894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05171894, "A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05171894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*